Fostemsavir Tromethamine
CAS 864953-39-9Small Molecule
Overview
Fostemsavir Tromethamine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL3301598).
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Fostemsavir Tromethamine expires 13 Jul 2029. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- 2-amino-2-(hydroxymethyl)propane-1,3-diol;[3-[2-(4-benzoylpiperazin-1-yl)-2-oxoacetyl]-4-methoxy-7-(3-methyl-1,2,4-triazol-1-yl)pyrrolo[2,3-c]pyridin-1-yl]methyl dihydrogen phosphate
- Canonical SMILES
- CC1=NN(C=N1)C2=NC=C(C3=C2N(C=C3C(=O)C(=O)N4CCN(CC4)C(=O)C5=CC=CC=C5)COP(=O)(O)O)OC.C(C(CO)(CO)N)O
- InChIKey
- RRGJSMBMTOKHTE-UHFFFAOYSA-N
Verified Supplier Partner
Do you supply Fostemsavir Tromethamine? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.